Gordon Alton
- Molecular Biology top 5%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Organic Chemistry top 5%
- Genetics top 10%
- Co-authors
- James G. ChristensenHelen Y. ZouBarbara MroczkowskiQiuhua LiShinji YamazakiJoseph H. LeeScott R. McDonnellGerrit Los
- Topics
- Glycosylation and Glycoproteins Research (12 papers)PI3K/AKT/mTOR signaling in cancer (8 papers)Carbohydrate Chemistry and Synthesis (8 papers)
- Cited by
- HepatologyOncologyMolecular Biology
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Gordon Alton
41 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Molecular Biology 1.8k
- Oncology 739
- Pulmonary and Respiratory Medicine 646
- Organic Chemistry 390
- Genetics 293
Countries citing papers authored by Gordon Alton
This map shows the geographic impact of Gordon Alton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Alton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Alton more than expected).
Fields of papers citing papers by Gordon Alton
This network shows the impact of papers produced by Gordon Alton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Alton. The network helps show where Gordon Alton may publish in the future.
Co-authorship network of co-authors of Gordon Alton
This figure shows the co-authorship network connecting the top 25 collaborators of Gordon Alton. A scholar is included among the top collaborators of Gordon Alton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon Alton. Gordon Alton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 12 | |
| 3 | 6 | |
| 4 | 11 | |
| 5 | 25 | |
| 6 | An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanismsbreakdown → | 593 |
| 7 | Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphomabreakdown → | 513 |
| 8 | 10 | |
| 9 | 8 | |
| 10 | 1 | |
| 11 | 107 | |
| 12 | 77 | |
| 13 | 2 | |
| 14 | 10 | |
| 15 | 6 | |
| 16 | 24 | |
| 17 | 7 | |
| 18 | 38 | |
| 19 | 23 | |
| 20 | 14 |
About Gordon Alton
Gordon Alton is a scholar working on Molecular Biology, Biotechnology and Biochemistry, having authored 42 papers that have together received 2.8k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (12 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Carbohydrate Chemistry and Synthesis (8 papers). The work is most often cited by research in Hepatology (246 citations), Oncology (739 citations) and Molecular Biology (1.8k citations). Gordon Alton has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include James G. Christensen, Helen Y. Zou, Barbara Mroczkowski, Qiuhua Li, Shinji Yamazaki, Joseph H. Lee, Scott R. McDonnell, Gerrit Los, Maria E. Arango and Mahnaz Razandi. Their work appears in journals such as Journal of Clinical Investigation, Gastroenterology and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.